Skip to main content
Yu Bai, MD, Pathology, Houston, TX, Memorial Hermann - Texas Medical Center

YuBaiMD

Pathology Houston, TX

Blood Banking & Transfusion Medicine, Molecular Genetics, Transplantation Immunology, Clinical Pathology

Assistant Professor, Pathology & Laboratory Medicine, University of Texas Medical School, Houston

Are you Dr. Bai?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 21 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Yu Bai, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and Virginia. She is affiliated with Memorial Hermann - Texas Medical Center and Memorial Hermann Physician Network.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2002
  • University of Virginia Medical Center
    University of Virginia Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2000 - 2001
  • Beijing Medical University
    Beijing Medical UniversityClass of 1987

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • VA State Medical License
    VA State Medical License 1998 - 2024
  • American Board of Pathology Clinical Pathology
  • American Board of Pathology Blood Banking/Transfusion Medicine
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Press Mentions

  • Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled Trial
    Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled TrialNovember 18th, 2020
  • Prevalence of Gastric Cancer Precursors in Gastroscopy-Screened Adults by Family History of Gastric Cancer and of Cancers Other Than Gastric
    Prevalence of Gastric Cancer Precursors in Gastroscopy-Screened Adults by Family History of Gastric Cancer and of Cancers Other Than GastricNovember 16th, 2020
  • Dizal Highlights Its Advances in Hematological Portfolio at 2023 ASH, Featuring Breakthroughs in Lymphoma Treatment
    Dizal Highlights Its Advances in Hematological Portfolio at 2023 ASH, Featuring Breakthroughs in Lymphoma TreatmentNovember 4th, 2023

Hospital Affiliations